SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), urgently needs effective prophylactic and therapeutic drugs. RNA-dependent RNA polymerase (RdRp), essential for replicating and transcribing a viral RNA genome, is highly conserved in coronaviruses; thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Jung Sun, Kwon, Sunoh, Jin, Young-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392292/
https://www.ncbi.nlm.nih.gov/pubmed/34440200
http://dx.doi.org/10.3390/biomedicines9080996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392292/
https://www.ncbi.nlm.nih.gov/pubmed/34440200
http://dx.doi.org/10.3390/biomedicines9080996

Ejemplares similares